Vion (formerly Oncorx) interesting play on Gene Therapy Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: who wrote ()	10/31/1996 7:13:00 AM
From: Rob C.	of 370

Steve and all....this is what we have been waiting for... 10/30/96 Vion Says Yale Hepatitis-Treating Compound Gets Patent>VION NEW HAVEN, Conn. (Dow Jones)--Vion Pharmaceuticals Inc. (VION) said Yale University received a patent covering the composition of matter and method of use for treating Hepatitis B virus infection with L-2', 3'-didehydro-dideoxy-5-florocytidine nucleoside analog, also known as B-L-Fd4C. In a press release, the company said it is exclusively licensing the product from Yale. Vion develops and commercializes oncology and antiviral products. (END) DOW JONES NEWS 10-30-96 6:08 PM Stock has alot of promise and at these levels is a screaming buy. Regards, Rob

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next